Abstract: Fibrin is widely used in different approaches of tissue engineering. Nevertheless, poor biomechanical strength restricts its use namely in cardiovascular tissue engineering. We have recently developed a novel moulding technique for the generation of highly stable fibrin tubes. The purpose of this study was the application of this method to the generation of small calibre fibrin tubes for the generation of bioartificial vascular grafts with a diameter of 3 mm. Therefore, a fibrinogen preparation was separated from plasma by means of cryoprecipitation and applied to a high-speed rotating casting mould in a low concentration to achieve slow polymerization and thereby uniform distribution of the fibrinogen. Thus, uniformly moulded 10 cm long fibrin tubes with a diameter of 3 mm were generated from 145±22 mg fibrinogen precipitated from 50 mL plasma. Thickness of the wall (522±57 μm) and biomechanical strength (47.4±11.1 kPa) were equable over the whole length of the tubes. Burst strength was 367±49 mm Hg. Thus, the developed technique enables the generation of tubular fibrin segments with a high biomechanical stability and represents a powerful tool for the generation of custom-made bioartificial vascular grafts.
Introduction
Fibrin has found to be a versatile scaffold material for tissue engineering (TE) approaches such as the engineering of bioartificial vascular grafts [1] [2] [3] [4] [5] [6] . But poor biomechanical strength has limited the use of fibrin matrices as scaffold material namely in the cardiovascular TE [7] . We recently reported about a novel method for the generation of tubular fibrin segments with a highly increased biomechanical strength [8] . It bases upon compaction of the fibrin in a high-speed rotating custom-made mould. So far the method has been established for the generation of 10 cm long fibrin tubes with a diameter of 5-5.5 mm from only 100 mg fibrin, which were successfully implanted as replacement of a segment of the carotid artery in a first in vivo trial [8] .
Nevertheless, despite of these very promising results, this technique could not directly be transferred on the engineering of small diameter fibrin tubes with a diameter of 3 mm. Deficient distribution of fibrin preparations in small diameter rotating moulds prevented equable thickness and biomechanical strength over the whole length of the tubes a prerequisite for the use as vascular graft material. But the advantage of bioartificial vascular grafts should even be their use as a small calibre vascular graft with a diameter of < 5 mm, for which until today no suitable synthetic graft material is clinically available.
The purpose of this study was the application of the developed method into the engineering of fibrin tubes with a diameter of 3 mm. To achieve a uniform distribution of fibrin over the whole mould, a cryoprecipitated low concentrated fibrin precipitation was used.
Results
By means of cryoprecipitation 145±22 mg fibrinogen were separated from 50 mL fresh frozen plasma (FFP). Precipitated fibrinogen was re-dissolved in 11 mL of supernatant serum. Thus, a fibrinogen preparation with a concentration of 13±3 mg fibrinogen per mL was obtained.
From the fibrinogen preparation fibrin tubes (n = 6) were generated in a high-speed (15,000 rpm) rotating mould. Average thickness of the wall of the fibrin tubes was 522±57 μm. No significant differences were found between the thickness of wall in the front (510±57 μm), the middle (510±28 μm) and the rear parts (540±70 μm) of the fibrin tubes (Figure 1) . Calculated from the dimensions of the fibrin tubes more than 95% of the applied fluid was drained out of the fibrin matrix.
Biomechanical characterization
Biomechanical characterization revealed burst strength of the fibrin tubes of 367±49 mm of mercury (mm Hg). The average tensile strength was 47.4±11.1 kPa with no significant differences between the front (48.1±7.4 kPa), the middle (47.8±15.9 kPa) and the rear section (46.5±12.3). Secant modulus of elasticity was 0.43±0.08 kPa/mm. For comparison burst strength of native ovine carotid artery (n = 6) was 975±150 mm Hg, tensile strength was 102±22 kPa and secant modulus 1.1±0.3 kPa/mm.
Elasticity was visualized in a stress-strain-curve in which the increase of length was recorded against the applied tensile strength. Graphs of both fibrin tubes and ovine carotid arteries showed a similar course, while the strength of the fibrin tubes was significantly lower (approx 45%). Calculated from the stress-strain-curve diameter of the fibrin tubes increased at 16 kPa corresponding to a pressure of 120 mm Hg inside the tube from 3 to 5.1 mm and at 26 kPa corresponding to a pressure of 200 mm Hg to 5.9 mm (Figure 2 ). 
Discussion
In this study we have successfully transferred a recently developed moulding technique for the construction of highly stable fibrin tubes to the engineering of smalldiameter tubes with a diameter of 3 mm. The resulting centrifugal forces in the high-speed rotating mould not only form the fibrin in the desired size and tubular shape, but also result in a significant increase in biomechanical stability allowing for an immediate implantation in the arterial system. In this setting an introduction of the applicator into the mould was not possible because of the small dimensions of the mould and vibrations of the application pen at high rotation velocities. The successful transfer of the technique to the production of small-diameter tubes could be achieved by the use of a fibrin preparation with a low concentration of only 13 mg/mL. At this low concentration polymerization runs out slowly within more than 1 min and allows for a uniform distribution of the applied fibrinogen preparation. In commercially available fibrin glue polymerization time of the fibrin is regulated by different thrombin solutions. In contrast, in our setting a relatively high thrombin concentration was required to achieve a sufficient stirring of fibrinogen preparation and activating thrombin-solution. Thereby, a uniform distribution of the slow polymerizing fibrinogen was obtained as was shown by an equable stability and thickness of the wall over the whole length of the tubes. While the drainage of excess fluid from the mould and thus out of the fibrin matrix is crucial for compaction of the fibrin affiliated with a significant increase of biomechanical strength, premature loss of slow polymerizing highly fluid fibrinogen preparation out of the mould had to be prevented. This was achieved by closing the draining holes in the mould at the beginning of the manufacturing process, while the mould was partially filled. After polymerization of the initially applied fibrinogen drainage of the fluid was allowed again, while polymerized fibrin served itself as a kind of filter to prevent loss of further applied fibrinogen but enabling drainage of excess fluid. By means of this technique, 10 cm long fibrin tubes with a diameter of 3 mm and burst strength of in mean 367 mm Hg were generated in less than one an hour.
While the graph of the stress-strain diagram shows a similar characteristic course as that of a native carotid artery, however, biomechanical strength of fibrin tubes was significantly lower. As a consequence their diameter increased at a tensile strength of the wall of 16 kPa corresponding to a pressure of 120 mm Hg inside the tube to 5.1 mm and to 5.9 mm at 26 kPa corresponding to 200 mm Hg. Therefore, although the present results are very promising so far, however, still further improvement of the biomechanical properties is required not only to allow the absorption of blood pressure peaks and additional strain by body movements, but also to provide a similar elasticity to avoid compliance and calibre mismatch.
Regarding the reduction of thrombogenicity of the fibrin tubes if used as a vascular graft, the manufacturing process allows for the simultaneous sequential seeding with smooth muscle cells and endothelial cells (EC) resulting in their hierarchical three-dimensional arrangement [8] . The seeding with autologous EC to reduce thrombogenicity of bioartificial cardiovascular devices has been established as a rationale of cardiovascular TE over the last decades. However, a seeding procedure together with the necessary cell-isolation and -expansion in vitro is not only time-and cost-intensive but also complicates the regulatory requirements for clinical approval. More and above, seeded bioartificial cardiovascular implants are considerably limited storable, and thus are only applicable for custom-made engineering before an elective implantation. However, immediate availability have emerged as crucial for a clinical use [9] . Therefore, reduction to the generation and implantation of a simple but fully biocompatible implant, which supports a remodelling process in vivo, seems to be more reasonable with regard to clinical use instead of the complex engineering of a neo-vessel in vitro [10] . In this context functionalization of the fibrin tubes by coating their surface or addition of bioactive factors, such as prostacyclin or heparin to inhibit platelet adhesion or fibrin deposition, appears to be a more feasible approach to ensure graft's antithrombogenicity during remodelling process in vivo and appears to be a key issue of ongoing research in the field of cardiovascular TE. Fibrin has found to be beneficial also for this in situ-TE called concept in terms of adhesion and proliferation of ingrowing cells [11] . The generation of a vascular graft with a minimum effort of time and costs will thereby have the greatest potential for a future clinical use. The developed method represents a powerful tool to consolidate the advantages of fibrin regarding its biocompatibility, the ability of attachment and three-dimensional arrangement of vascular cells inside the matrix and the capability of modelling it in nearly all size and shape in the construction of a clinically usable vascular graft.
Materials and methods
Fibrinogen was precipitated by a freeze-thaw-cycle (cryoprecipitation) from FFP, which were obtained from the blood bank of the Medical School Hannover, since they were not applicable for clinical use for any reason and stored at -80 °C. Frozen plasma was thawed gently at room temperature and after complete thawing centrifuged at 450 × g for 3 min. The precipitated fibrinogen pellet was dissolved in supernatant serum to a volume of 11 mL. Concentration of fibrinogen was measured by means of an enzyme-linked immunosorbant assay (ELISA) (Innovative Research, Novi, MI, USA) according to manufacturer's instructions.
For the engineering of fibrin tubes the fibrinogen preparation was applied into the rotating mould simultaneously with an activating thrombin-solution in a ratio 4.6:1. The thrombin-solution was composed of a hydrous calcium chloride solution (100 mmol/L) with 500 units of thrombin (Vascular Solutions, Minneapolis, MN, USA), 1000 units of aprotinin (Loxo, Germany) and 300 units factor XIII (Fibrogammin, Behring CSL, Germany) per mL. Application was done using the Vivostat ® -application unit (Vivostat, Denmark). Fibrinogen-preparation (5.5 mL) and activating thrombin-solution (1.2 mL) were placed in the application unit using the manufacturer's syringes. The application pen itself contains three separate channels for: (i) the application of the fibrinogen-preparation, (ii) the application of the thrombin-solution, (iii) a channel for air supply to transport/spray the applied solutions. The Vivostat ® -application pen was mounted on a mobile slide. During application it was placed at one end of the rotating mould with only the tip introduced to the mould.
The custom-made high-speed rotating casting mould consisted of an outer brass tube. Seven pairs of drill holes (diameter 0.5 mm) within the brass tube allowed for the drainage of excess fluid ( Figure  3A) . Two removable Teflon ® half shells were placed inside the outer brass enclosing a 100 mm long and 4 mm wide central cavity. Teflon ® cuffs narrowed the lumen to enclose the central cavity at both ends and prevented loss of the applied fibrin. Inside the cuffs 2 mm wide central drill holes allow for the application of the fibrin and air vent during the manufacturing process. The casting mould was driven by an electric motor with a rotation velocity of 15,000 rpm according to a g-force of 500 g acting on the applied fibrin inside the mould.
Before the application the holes in the mould were masked to prevent premature loss of the highly fluid fibrinogen preparation. The manufacturing process started with the application of 1 mL fibrinogen preparation to partially fill up the mould. After 2 min. of rotation the mould was stopped and the holes in the mould were opened to allow removal of excess fluid. Rotation of the mould was started again, and 5 min afterwards the remaining fibrinogen preparation together with the thrombin-solution was applied. Afterwards rotation of the mould was continued until no more fluid was drained out of the mould (20-30 min).
For analysis of the wall thickness specimens of each fibrin tube were fixed overnight in paraformaldehyde (4% at 4 °C) and moulded in paraffin. Wall thickness were measured on digital photographs of light microscopic views (Axio Observer, Zeiss Jena, Germany) of 10 μm paraffin sections of each specimen using the digital image processing software Axio vision (version 4.8.2, Zeiss Jena, Germany).
For biomechanical characterization burst strength and tensile strength of the generated fibrin tubes and of native ovine carotid artery were measured. Data of biomechanical characterization of carotid arteries were taken from a previously conducted in vivo-study [8] . Direct measurement of the burst strength was done in a custommade device, where a 3 cm long specimen of each tube was filled with saline solution until its rupture. Pressure was recorded and the burst strength defined as the highest pressure recorded before structural failure. To determine the tensile strength specimens (1 × 1 cm) were taken from each tube from the front, middle and rear part. Samples were placed in longitudinal and cross direction in a mechanical testing device (ATP Messtechnik, Germany) and pulled apart until structural failure. The resulting tensile strength was defined as the highest force (N/cm 2 = 10 kPa) recorded before rupture. Elasticity was drawn as the increase of length of specimen against the pressure, which was calculated from the applied tensile strength by the formula: 1 kPa/7.5 = 1 mm Hg. Additionally, elasticity of the fibrin tubes and native carotid arteries was indexed as secant modulus of elasticity (SM) and calculated by the formula: max. tensile strength/Δ length at the point of structural failure. (1) was driven by an electric motor (2) with a rotation velocity of 15,000 rpm. The pen of the application unit (4) was mounted on an adjustable mobile slide (3).
